NEW YORK, April 15 (GenomeWeb News) - Part of a $100,000 grant from Japanese drug maker Sankyo Pharma will go to help the University of Buffalo's School of Pharmacy and Pharmaceutical Sciences to buy "new analytical equipment" for pharmacogenomics research, according to a local media report.
The rest of the money from the Edison, N.J.-based division of Sankyo Pharma will help pay for teaching and training at the pharmaceutical department, the Buffalo Reporter said.
Daniel Salazar, senior director of clinical pharmacology and pharmacokinetics for Sankyo, helped organize the deal. He is a graduate of the University of Buffalo School of Pharmacy.